NASDAQ:QTNT

Quotient - QTNT Stock Forecast, Price & News

$0.15

0.00 (0.00%)

(As of 09/30/2022 09:01 PM ET)

Add

Compare

Today's Range: $0.15
▼
$0.16
50-Day Range: $0.15
▼
$0.28
52-Week Range: $0.14
▼
$3.19

Volume: 708,200 shs
Average Volume: 1.80 million shs
Market Capitalization: $15.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.25

Quotient MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 1,400.0% Upside
$2.25 Price Target
Short Interest: Healthy
3.14% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -1.83
Upright™ Environmental Score
News Sentiment: 0.36
Based on 7 Articles This Week
Insider Trading: Acquiring Shares
$175,000 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.69) to ($0.32) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

131st out of 1,095 stocks

Diagnostic Substances Industry

3rd out of 17 stocks

3.4

Analyst's Opinion

Consensus Rating
Quotient has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.25, Quotient has a forecasted upside of 1,400.0% from its current price of $0.15.
Amount of Analyst Coverage
Quotient has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.14% of the outstanding shares of Quotient have been sold short.
Short Interest Ratio / Days to Cover
Quotient has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Quotient has recently decreased by 1.82%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Quotient does not currently pay a dividend.
Dividend Growth
Quotient does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Quotient has received a 58.45% net impact score from Upright. Quotient seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Taxes". The positive contribution in the "Physical diseases" impact category is driven by its "Hematology analyzers" and "Laboratory reagents" products. See details.
Environmental Sustainability
The Environmental Impact score for Quotient is -1.83.

1.9

News and Social Media Coverage

News Sentiment
Quotient has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Quotient this week, compared to 4 articles on an average week.
Search Interest
Only 5 people have searched for QTNT on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
MarketBeat Follows
Only 10 people have added Quotient to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Quotient insiders have bought more of their company's stock than they have sold. Specifically, they have bought $175,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
10.50% of the stock of Quotient is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
86.84% of the stock of Quotient is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Quotient are expected to grow in the coming year, from ($0.69) to ($0.32) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Quotient is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Quotient is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Quotient (NASDAQ:QTNT) Stock

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Receive QTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.

QTNT Stock News Headlines

September 28, 2022 | finance.yahoo.com

Insiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20m - Yahoo Finance

September 28, 2022 | businesswire.com

Quotient's Omnichannel Measurement Now Combines Promotions with Media to Ensure Every Shoppable Moment is Attributable - Business Wire

September 28, 2022 | finance.yahoo.com

Insiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20m

September 27, 2022 | americanbankingnews.com

Quotient (NASDAQ:QTNT) Now Covered by StockNews.com

September 26, 2022 | bizjournals.com

What are the most unique jobs in Buffalo, New York? - Buffalo Business First - The Business Journals

September 23, 2022 | washingtonpost.com

‘Catherine Called Birdy’: Lena Dunham's Y.A. take on the patriarchy - The Washington Post

September 19, 2022 | washingtonpost.com

British royal family has inspired souvenir collectors for decades - The Washington Post

September 12, 2022 | bizjournals.com

These are the 33 highest-paying jobs in the Buffalo metro area - Buffalo Business First - The Business Journals

September 9, 2022 | benzinga.com

Thinking about buying stock in Nio, Quotient, Mogu, Rivian Automotive, or LYFT?

September 9, 2022 | finance.yahoo.com

The Best (and Worst) Cities for People Without a College Degree - Yahoo Finance

September 8, 2022 | globenewswire.com

Quotient Limited Selected to Join the World Economic Forum New Champions Community - GlobeNewswire

September 8, 2022 | finance.yahoo.com

Quotient Limited Selected to Join the World Economic Forum New Champions Community

September 7, 2022 | benzinga.com

MIDWEST ENERGY EM (MEEC), Quotient Ltd (QTNT) – Quotient And 2 Other Stocks Under $1 Insiders Are Buying - Benzinga

September 1, 2022 | bizjournals.com

The key to success is AQ. Does your organization have it? - The Business Journals

August 31, 2022 | washingtonpost.com

Opinion | Here's why the Trump GOP's crazy quotient is expanding - The Washington Post

August 31, 2022 | benzinga.com

HCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 I - Benzinga

August 31, 2022 | washingtonpost.com

Serena Williams's daughter, Olympia, basks in U.S. Open spotlight - The Washington Post

August 25, 2022 | seekingalpha.com

Quotient expands MosaiQ Innovator's Circle - Seeking Alpha

August 24, 2022 | streetinsider.com

Quotient Limited Expands MosaiQ Innovator's Circle to Empower Patient Care and Laboratory Efficiencies - StreetInsider.com

August 24, 2022 | globenewswire.com

Quotient Limited Expands MosaiQ Innovator's Circle to - GlobeNewswire

August 24, 2022 | finance.yahoo.com

Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies

August 23, 2022 | benzinga.com

Thinking about buying stock in Avaya Holdings, Quotient, Aurora Cannabis, Marin Software, or Macy's? - Benzinga

August 17, 2022 | businesswire.com

Quotient Unveils Multi-Touch Attribution to Drive Digital Out-of-Home Investment Among Ad Buyers - Business Wire

August 11, 2022 | businesswire.com

Quotient Wins Second MarTech Breakthrough Award for Influencer Marketing Innovation - Business Wire

August 10, 2022 | finance.yahoo.com

Quotient Technology Inc. Announces Second Quarter 2022 Results - Yahoo Finance

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive QTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.

QTNT Company Calendar

Last Earnings: 8/09/2022
Today: 10/02/2022
Next Earnings (Estimated): 11/21/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:QTNT
CUSIP: N/A
CIK: 1596946
Web: www.quotientbd.com
Phone: (122) 716-9800
Fax: N/A
Employees: 426
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $2.25
High Stock Price Forecast: $3.00
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +1,400.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.34)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-125,130,000.00
Net Margins: -357.50%
Pretax Margin: -356.39%
Return on Equity: N/A
Return on Assets: -66.13%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.00
Quick Ratio: 2.23

Sales & Book Value

Annual Sales: $38.51 million
Price / Sales: 0.40
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.40) per share
Price / Book: -0.11

Miscellaneous

Outstanding Shares: 103,216,000
Free Float: 92,378,000
Market Cap: $15.48 million
Optionable: Optionable
Beta: 2.76

Key Executives

Mr. Manuel O. Mendez (Age 54)
CEO & Director
Comp: $10.22M

Mr. Ali Kiboro (Age 47)
Chief Financial Officer
Comp: $798.9k

Mr. Mohammad El Khoury (Age 62)
Chief Commercial Officer
Comp: $544.83k

Ms. Vittoria Bonasso (Age 46)
Head of Fin., Group Controller & Principal Accounting Officer

Dr. Michael Hausmann
Chief Technology Officer

Dr. Christine Ginocchio
Chief Scientific & Medical Officer

Ms. Viviane Montarnal
Head of Legal Affairs & Compliance

Ms. Hyatt Antognini
Head of Corp. Communications

Mr. Christian Albrich (Age 58)
Chief People Officer

Mr. Esteban Uriarte
Chief Manufacturing Operations Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

QTNT Stock - Frequently Asked Questions

Should I buy or sell Quotient stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" QTNT shares.
View QTNT analyst ratings or view top-rated stocks.
What is Quotient's stock price forecast for 2022?: 4 brokerages have issued twelve-month price objectives for Quotient's stock. Their QTNT share price forecasts range from $1.50 to $3.00. On average, they expect the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 1,400.0% from the stock's current price.
View analysts price targets for QTNT or view top-rated stocks among Wall Street analysts.
How have QTNT shares performed in 2022?: Quotient's stock was trading at $2.59 at the start of the year. Since then, QTNT stock has decreased by 94.2% and is now trading at $0.15.
View the best growth stocks for 2022 here.
When is Quotient's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our QTNT earnings forecast.
How were Quotient's earnings last quarter?: Quotient Limited (NASDAQ:QTNT) posted its quarterly earnings data on Tuesday, August, 9th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by $0.09. The business had revenue of $8.81 million for the quarter, compared to analyst estimates of $9.40 million.
What guidance has Quotient issued on next quarter's earnings?: Quotient issued an update on its FY 2023 earnings guidance on Tuesday, September, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $39.00 million-$42.00 million, compared to the consensus revenue estimate of $40.87 million.

What other stocks do shareholders of Quotient own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Quotient investors own include VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Verastem (VSTM), Cidara Therapeutics (CDTX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), SCYNEXIS (SCYX), Novavax (NVAX), Ocular Therapeutix (OCUL) and Sorrento Therapeutics (SRNE).
What is Quotient's stock symbol?: Quotient trades on the NASDAQ under the ticker symbol "QTNT."
How do I buy shares of Quotient?: Shares of QTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Quotient's stock price today?: One share of QTNT stock can currently be purchased for approximately $0.15.
How much money does Quotient make?: Quotient (NASDAQ:QTNT) has a market capitalization of $15.48 million and generates $38.51 million in revenue each year. The company earns $-125,130,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis.
How many employees does Quotient have?: The company employs 426 workers across the globe.
How can I contact Quotient?: Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The official website for the company is www.quotientbd.com. The company can be reached via phone at (122) 716-9800 or via email at ir@quotientbd.com.

This page (NASDAQ:QTNT) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Quotient - QTNT Stock Forecast, Price & News

Quotient MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows